Meeting Report: Strategic Workshops on Cancer Nanotechnology

comprehensive, systematized effort encompassing the academic and private sectors in multidisciplinary research and dedicated to the use of nanotechnology in cancer prevention, diagnosis, and therapy. The program is designed to move basic science discoveries into the development pipeline and eventually into clinical use. As the program approaches the midway point of its five-year funding, NCI is once again assessing the field of cancer nanotechnology to determine the current needs and gaps in this area of research. Toward that end, the NCI’s Office of Technology and Industry Relations (OTIR) held three strategic workshops on cancer nanotechnology covering the areas of in-vitro diagnostics and prevention, in-vivo diagnosis and imaging, therapy and post-treatment. To each of these meetings, NCI’s program staff invited a wide range of experts from academia, industry, the non-profit sector, and the Federal government